Optimising RAASi Management in Cardiorenal Patients: An Expert Roundtable
Published: 23 April 2024
-
Views:
8767
-
Likes:
7
-
Views:
8767
-
Likes:
7
-
Up Next -
9m 20sPart 2 | Session 2 Panel Discussion and Q&A
-
1m 15sPart 3 Key Learnings / Summary
-
15m 4sPart 1 | Session 1 Background and Guidelines Andrew Frankel, Shelley Zieroth, Aaron Wong, Manish Sood
-
9m 23sPart 1 | Session 2 Case Presentation Aaron Wong
-
14m 31sPart 1 | Session 3 Panel Discussion and Q&A Andrew Frankel, Shelley Zieroth, Aaron Wong, Manish Sood
Overview
In this on-demand version of the live roundtable, cardiologists Dr Shelley Zieroth (University of Manitoba, Winnipeg, CA) and Dr Aaron Wong (Princess of Wales Hospital, Wales, UK) join nephrologists Dr Andrew Frankel (Imperial College Healthcare NHS Trust, London, UK), and Dr Manish Sood (University of Ottawa, CA) to discuss the nuanced landscape of RAASi management in cardiorenal patients.
In this discussion, our expert faculty consider approaches to optimal RAASi dosing and strategies to improve patient outcomes. The programme integrates data-driven insights, established guidelines, and expert consensus, offering participants a holistic understanding of RAASi management.
A case study highlights how to overcome barriers to optimal guideline-directed medical therapy and panel discussion will bridge theory and real-world application, providing you with actionable tools to implement optimal practices in your daily clinical pursuits.
Learning Objectives
- Describe the prevalence and clinical impact of sub-optimal RAASi use in cardiorenal patients
- Recall key messages from current guidelines, consensus and clinical evidence for optimised RAASi management in cardiorenal patients
- Describe common barriers to optimise RAASi management strategies
- Use expert-led guidance to develop a practical approach to overcoming the barriers to RAASi use and the reinitiation/up-titration of therapy
Target Audience
- Cardiologists
- Heart Failure Specialists
- Nephrologists
- Other Allied HCPs
More from this programme
Part 1
RAASi Management in CKD/HF: What We Should Be Doing
Part 2
RAASi Management in CKD/HF: What Is Happening in The Real World?
Part 3
Key Learnings / Summary
| 1 session | |
| Key Learnings / Summary | Watch now |
Faculty Biographies
Manish Sood
Assistant Professor of Medicine
Dr Manish Sood is an Assistant Professor of Medicine at the University of Ottawa with cross appointment at the School of Epidemiology and Public Health, Scientist at the Ottawa Hospital Research Institute and the Institute for Clinical Evaluative Sciences, Deputy Editor- in- Chief and founder of the Canadian Journal of Kidney Health and Disease, and holds the Jindal Research Chair for the Prevention of Kidney Disease.
He completed his undergraduate (BSc) at Carleton and Lancaster University (UK) followed by medical school, internal medicine and nephrology residency training at the University of Toronto. He began his career as a clinical nephrologist at the St Boniface Hospital in Winnipeg, Manitoba, gradually developing an interest in research and clinical epidemiology and in 2013 became a clinician scientist. He completed his Masters in Science in Epidemiology at the University of Ottawa.
Comments